GlaxoSmithKline-Sanofi report positive results in trials of Covid-19 vaccine

"We believe that this vaccine candidate can make a significant contribution to the ongoing fight against Covid-19."
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.